Thu, Jul 10, 2014, 5:13 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • stockvadar stockvadar Aug 24, 2013 8:41 PM Flag

    Why Belviq Refills Are Out-Pacing Qsymia, I'll explain. Stockvadar-offers

    Investors. To explain how Belviq (B) has overtaken Qsymia's (Q) refill growth, I'll explain. Starting with 6/14/13, watch the growth pace wk/wk of refills ONLY for the last 10 weeks (why I use 10 weeks is for a direct comparison between Belviq vs Qsymia).

    6/7/13..................Q=1169
    6/14/13 B=6 (0 growth) vs Q=1812 (+643 growth)
    6/21/13 B=58 (+52 growth) vs Q=1262 (-550 loss)
    6/28/12 B=104 (+46 growth) vs Q=1205 (-57 loss)
    7/5/13 B=146 (+42 growth) vs Q=1204 (-1 loss)
    7/12/13 B=249 (+103 growth) vs Q=1281 (+77 growth)
    7/19/13 B=343 (+94 growth) vs Q=1325 (+44 growth)
    7/26/13 B=380 (+37 growth) vs Q=1313 (-12 loss)
    8/2/13 B=458 (+78 growth) vs Q=1512 (+199 growth)
    8/9/13 B=454 (-4 loss) vs Q=1378 (-134 loss)
    8/16/13 B=528 (+74 growth) vs Q=1510 (+132 growth)

    Starting 6/14/13, Belviq growth = Refills total +522 over 10 weeks
    Starting 6/14/13, Qsymia growth = Refills total +341 over 10 weeks

    As you can see, Belviq over 10 weeks has out-paced Qsymia's refill growth. That is a fact. -SV

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ARNA
5.06+0.11(+2.22%)Jul 10 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.